The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.
 
Alberto Pavan
No Relationships to Disclose
 
Elisabetta Zulato
No Relationships to Disclose
 
Lorenzo Calvetti
No Relationships to Disclose
 
Alessandra Ferro
No Relationships to Disclose
 
Giorgia Nardo
No Relationships to Disclose
 
Alice Boscolo
No Relationships to Disclose
 
Ilaria Attili
No Relationships to Disclose
 
Stefano Frega
No Relationships to Disclose
 
Alessandro Dal Maso
No Relationships to Disclose
 
Giulia Pasello
No Relationships to Disclose
 
Valentina Guarneri
Consulting or Advisory Role - Lilly; Novartis; Roche
Speakers' Bureau - Lilly; Novartis
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Tesaro
 
Giuseppe Aprile
No Relationships to Disclose
 
Pier Franco Conte
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; Novartis; Roche/Genentech; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis; Pfizer
 
Stefano Indraccolo
No Relationships to Disclose
 
Laura Bonanno
No Relationships to Disclose